EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Estimating the potential economic and health impact of integrated genomic surveillance in a hospital setting

Frederik Boetius Hertz, Karen Leth Nielsen, Dmytro Strunin, Jelena Erdmann, Martin Lucas Jørgensen, Theiss Bendixen, Roshkan Srinathan, Rasmus L Marvig, Steen Christian Rasmussen, Asger Nellemann Rasmussen, Christian Salgaard Jensen, Jenny Dahl Knudsen und 1 weitere

Clinical Microbiology and Infection · 2026

DOI: 10.1016/j.cmi.2025.09.021 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Microbiology and Infection, 2026. Verfasst von Frederik Boetius Hertz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen Ø, Denmark; Department of Immunology & Microbiology, F…. Hauptthemen laut MEDLINE: Cross Infection, Bacteria, Bacterial Infections, Epidemiological Monitoring. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danmarks Frie Forskningsfond, Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Integrated genomic surveillance, combining whole genome sequencing (WGS) of bacterial isolates with patient movement data, promises improved detection and prevention of pathogen transmission. However, evidence on its cost-effectiveness and clinical utility remains limited, not least because the full extent of transmission in hospital settings is difficult to capture. METHODS: We conducted a 28-month observational study at Rigshospitalet, Copenhagen, collecting patient movement data and sequencing 18 438 bacterial isolates from 7398 patients across diverse species, infection sites, and resistance profiles. We estimated the hypothetical benefits of implementing integrative WGS surveillance, assuming that continued transmission could be prevented when WGS information was acted upon immediately. RESULTS: We found that 1975 of 7398 of culture-positive hospitalized patients (26.7%) harboured a pathogen genetically related to another patient's isolate. Of those, 1359 (68.8%) had an epidemiological link in the hospital, with Enterococcus faecium by far being the most prevalent bacteria involved in transmissions. WGS-informed prevention could hypothetically generate a net savings of €1.35 million annually if transmission was stopped once a clonal isolate was detected in a second patient. Furthermore, this approach could potentially have prevented an estimated 1284 hospital-acquired infections over the 28-month study period, including 94 cases characterized by the recovery of bloodstream isolates. CONCLUSIONS: Our integrated genomic surveillance approach reveals previously unexplored transmission landscapes. We discovered that transmission is widespread, varies between species, and is not limited to resistant isolates. Our results emphasize the potential of integrated genomic surveillance, the identification of local transmission hotspots, potential for greater savings by including susceptible isolates, and an incremental cost-effectiveness ratio classification by pathogen species.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross InfectionBacteriaBacterial InfectionsEpidemiological MonitoringHumansWhole Genome SequencingDenmarkHospitalsCost-Benefit AnalysisGenome, BacterialGenomics

Stichwörter der Autor:innen

Integrated genomic surveillanceProspective WGS of clinical isolatesTransmission hotspotsTransmission of susceptible isolates

Autor:innen und Institutionen

  • Department of Clinical Microbiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen Ø, Denmark; Department of Immunology & Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copen…
  • Department of Clinical Microbiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen Ø, Denmark.
  • Department Molecular Bacteriology, Helmholtz Centre for Infection Research, Braunschweig, Germany; Twincore Centre for Experimental and Clinical Infection Research, Hannover, Germany.
  • Nordic Healthcare Group, Copenhagen, Denmark.
  • Department of Genomic Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen Ø, Denmark.
  • Department of Clinical Microbiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen Ø, Denmark; Department Molecular Bacteriology, Helmholtz Centre for Infection Research, Braunschweig, Germany; Twincore Cent…

Förderung

  • Danmarks Frie Forskningsfond
  • Novo Nordisk Foundation

Zitieren

APA

Hertz, F. B., Nielsen, K. L., Strunin, D., Erdmann, J., Jørgensen, M. L., Bendixen, T., Srinathan, R., Marvig, R. L., Rasmussen, S. C., Rasmussen, A. N., Jensen, C. S., Knudsen, J. D., & Häussler, S. (2026). Estimating the potential economic and health impact of integrated genomic surveillance in a hospital setting. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2025.09.021

Vancouver

Hertz FB, Nielsen KL, Strunin D, Erdmann J, Jørgensen ML, Bendixen T, et al. Estimating the potential economic and health impact of integrated genomic surveillance in a hospital setting. Clinical Microbiology and Infection. 2026. doi:10.1016/j.cmi.2025.09.021

BibTeX
@article{Hertz2026,
  author = {Hertz, Frederik Boetius and Nielsen, Karen Leth and Strunin, Dmytro and Erdmann, Jelena and Jørgensen, Martin Lucas and Bendixen, Theiss and Srinathan, Roshkan and Marvig, Rasmus L and Rasmussen, Steen Christian and Rasmussen, Asger Nellemann and Jensen, Christian Salgaard and Knudsen, Jenny Dahl and Häussler, Susanne},
  title = {Estimating the potential economic and health impact of integrated genomic surveillance in a hospital setting},
  journal = {Clinical Microbiology and Infection},
  year = {2026},
  doi = {10.1016/j.cmi.2025.09.021}
}
Kostenlos starten →